Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/20/2022 | Press release | Distributed by Public on 01/19/2022 21:48
Please select the service you want to use:
Smartlinks | ResApp Health Limited | News | Health | Medical Technology | Healthcare Equipment and Services | Technology | Medical Technology | Science | Research | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Manufacturing | Information Technology | Software | Public Companies | Medical Technology Companies | Börse Frankfurt | Australian Securities Exchange (ASX) | Chi-X Australia
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact